Baxter Long-Term Investments 2010-2024 | BAX
- Baxter long-term investments for the quarter ending June 30, 2024 were $M, a NAN% increase year-over-year.
- Baxter long-term investments for 2023 were $0B, a NAN% decline from 2022.
- Baxter long-term investments for 2022 were $0B, a NAN% decline from 2021.
- Baxter long-term investments for 2021 were $0B, a NAN% decline from 2020.
Baxter Annual Long-Term Investments (Millions of US $) |
|
---|---|
2023 | $ |
2022 | $ |
2021 | $ |
2020 | $ |
2019 | $ |
2018 | $ |
2017 | $ |
2016 | $ |
2015 | $ |
2014 | $ |
2013 | $ |
2012 | $ |
2011 | $ |
2010 | $ |
2009 | $ |
Baxter Quarterly Long-Term Investments (Millions of US $) |
|
---|---|
2024-06-30 | |
2024-03-31 | |
2023-12-31 | |
2023-09-30 | |
2023-06-30 | |
2023-03-31 | |
2022-12-31 | |
2022-09-30 | |
2022-06-30 | |
2022-03-31 | |
2021-12-31 | |
2021-09-30 | |
2021-06-30 | |
2021-03-31 | |
2020-12-31 | |
2020-09-30 | |
2020-06-30 | |
2020-03-31 | |
2019-12-31 | |
2019-09-30 | |
2019-06-30 | |
2019-03-31 | |
2018-12-31 | |
2018-09-30 | |
2018-06-30 | |
2018-03-31 | |
2017-12-31 | |
2017-09-30 | |
2017-06-30 | |
2017-03-31 | |
2016-12-31 | |
2016-09-30 | |
2016-06-30 | |
2016-03-31 | |
2015-12-31 | |
2015-09-30 | |
2015-06-30 | |
2015-03-31 | |
2014-12-31 | |
2014-09-30 | |
2014-06-30 | |
2014-03-31 | |
2013-12-31 | |
2013-09-30 | |
2013-06-30 | |
2013-03-31 | |
2012-12-31 | |
2012-09-30 | |
2012-06-30 | |
2012-03-31 | |
2011-12-31 | |
2011-09-30 | |
2011-06-30 | |
2011-03-31 | |
2010-12-31 | |
2010-09-30 | |
2010-06-30 | |
2010-03-31 | |
2009-12-31 | |
2009-09-30 | |
2009-06-30 | |
2009-03-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $18.264B | $14.813B |
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $204.059B | 26.03 |
Stryker (SYK) | United States | $139.868B | 31.52 |
Boston Scientific (BSX) | United States | $124.863B | 35.90 |
Medtronic (MDT) | Ireland | $114.537B | 17.04 |
EssilorLuxottica (ESLOY) | France | $110.799B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $45.365B | 0.00 |
Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
GE HealthCare Technologies (GEHC) | United States | $39.743B | 20.61 |
ResMed (RMD) | United States | $35.761B | 29.39 |
Terumo (TRUMY) | Japan | $28.532B | 40.29 |
Koninklijke Philips (PHG) | Netherlands | $25.454B | 19.48 |
Zimmer Biomet Holdings (ZBH) | United States | $21.582B | 13.74 |
Insulet (PODD) | United States | $16.648B | 70.04 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.052B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $10.282B | 35.10 |
BellRing Brands (BRBR) | United States | $8.726B | 36.90 |
Demant (WILYY) | Denmark | $8.351B | 0.00 |
Lantheus Holdings (LNTH) | United States | $8.016B | 19.24 |
ICU Medical (ICUI) | United States | $4.201B | 40.09 |
TG Therapeutics (TGTX) | United States | $3.771B | 0.00 |
Haemonetics (HAE) | United States | $3.763B | 18.61 |
Envista Holdings (NVST) | United States | $3.662B | 27.28 |
Prestige Consumer Healthcare (PBH) | United States | $3.657B | 18.22 |
Perrigo (PRGO) | Ireland | $3.466B | 10.95 |
Neogen (NEOG) | United States | $3.127B | 36.08 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $2.988B | 18.00 |
QuidelOrtho (QDEL) | United States | $2.628B | 16.56 |
Agios Pharmaceuticals (AGIO) | United States | $2.557B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.260B | 38.14 |
LeMaitre Vascular (LMAT) | United States | $2.165B | 52.65 |
Curaleaf Holdings (CURLF) | Canada | $2.023B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.960B | 0.00 |
Warby Parker (WRBY) | United States | $1.769B | 0.00 |
AtriCure (ATRC) | United States | $1.641B | 0.00 |
InMode (INMD) | Israel | $1.460B | 8.78 |
AdaptHealth (AHCO) | United States | $1.365B | 9.85 |
Verano Holdings (VRNOF) | United States | $1.231B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.179B | 0.00 |
Evolus (EOLS) | United States | $1.036B | 0.00 |
Owens & Minor (OMI) | United States | $0.925B | 7.23 |
National Vision Holdings (EYE) | United States | $0.915B | 29.08 |
Phibro Animal Health (PAHC) | United States | $0.906B | 18.80 |
CeriBell (CBLL) | United States | $0.893B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.844B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.542B | 16.36 |
Surmodics (SRDX) | United States | $0.536B | 113.85 |
Quanterix (QTRX) | United States | $0.532B | 0.00 |
Canopy Growth (CGC) | Canada | $0.515B | 0.00 |
Valneva SE (VALN) | France | $0.475B | 0.00 |
ZimVie (ZIMV) | United States | $0.398B | 33.56 |
Viemed Healthcare (VMD) | United States | $0.331B | 35.54 |
Aurora Cannabis (ACB) | Canada | $0.328B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.315B | 8.12 |
TerrAscend (TSNDF) | Canada | $0.309B | 0.00 |
Jin Medical (ZJYL) | China | $0.308B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
Cerus (CERS) | United States | $0.290B | 0.00 |
Biote (BTMD) | United States | $0.280B | 12.93 |
Ayr Wellness (AYRWF) | United States | $0.279B | 0.00 |
Zynex (ZYXI) | United States | $0.255B | 53.33 |
Omeros (OMER) | United States | $0.246B | 0.00 |
High Tide (HITI) | Canada | $0.234B | 97.00 |
MacroGenics (MGNX) | United States | $0.232B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.225B | 15.14 |
Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
Brainsway (BWAY) | Israel | $0.172B | 206.40 |
FitLife Brands (FTLF) | United States | $0.145B | 19.54 |
Rockwell Medical (RMTI) | United States | $0.121B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.117B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
Veru (VERU) | United States | $0.107B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 23.90 |
Fonar (FONR) | United States | $0.092B | 9.51 |
Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.082B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.079B | 0.00 |
InterCure (INCR) | Israel | $0.079B | 0.00 |
Modular Medical (MODD) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.065B | 0.00 |
Sanuwave Health (SNWVD) | United States | $0.064B | 1.63 |
MariMed (MRMD) | United States | $0.062B | 0.00 |
Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.045B | 0.00 |
Exagen (XGN) | United States | $0.043B | 0.00 |
Apyx Medical (APYX) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Flora Growth (FLGC) | United States | $0.020B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
Nephros (NEPH) | United States | $0.015B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.006B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 17.87 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |